ARCHIVES

Sirolimus-Containing Therapy Reduces GVHD, Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Contracts Awarded For $30 Million Heavy Smokers Clinical Trials

October 10, 1986

DeVita: No Decision Yet On FCRF Award

July 17, 1987

Cooperative Group Chairmen, OPRR Seek Agreement On Assurances

January 6, 1984

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

April 27, 2012

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009